Global Market Study on Stromal Vascular Fraction: Applications in Soft Tissue Prevail, Cosmetic Applications Create Lucrative Opportunities

Wednesday, June 6, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 5, 2018 /PRNewswire/ -- Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient's own body.In stromal vascular fraction treatment isolation of tissue contains fat cells, blood cells, and endothelial cells, as well as a large fraction of adipose-derived mesenchymal stem cells which provides regenerative properties and have positive anti-aging properties.

Read the full report: A stromal vascular fraction is considered as a personalized stem cell therapy and effective tropical or injectable treatment.With increasing age, regenerative and repair
properties of skin are less effective due to decrease in stem cell count, and therefore, stromal vascular fraction treatment contains stem cell provides a boost in repair and maintenance mechanism of the skin leaving smooth, healthy, radiant skin.Stromal vascular fraction is a naturally occurring stem cell found in bundles of adipose tissues and are the primary source of growth factors along with macrophages and other cells.Due to the presence of growth factors, the stromal vascular fraction is utilized to decrease inflammation present in many diseases. A stromal vascular fraction is adopted in the treatment of rheumatoid arthritis, joint replacement, osteoarthritis, diabetes, Crohn's disease, and others.Stromal Vascular Fraction Market: OverviewStromal vascular fraction is a combination of adipose-derived stromal cells (ADSCs), endothelial cells (ECs), endothelial precursor cells (EPCs), smooth muscle cells, macrophages, pericytes, and pre-adipocytes in the aqueous state.Stromal vascular fraction is advantageous over alternative medical treatments as SVF has the ability to regulate patient's own system with the main focus on cell repair and regulation of defective cells.Stromal vascular fraction is a promising field for disease prophylaxis and currently are in clinical trials.The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.It also contains projections using a suitable set of assumptions and methodologies.The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.The report covers exhaustive analysis on:Market SegmentsMarket DynamicsMarket SizeSupply & DemandCurrent Trends/Issues/ChallengesCompetition & Companies involvedTechnologyValue ChainStromal Vascular Fraction Market: SegmentationThe global stromal vascular fraction market can be segmented on the basis of type of therapy, end-user, and region.By Therapy TypeSVF Isolation ProductsEnzymatic IsolationNon-enzymatic IsolationAutomated POC DevicesSVF Aspirate Purification ProductsSVF Transfer ProductsBy End-userHospitalsSpecialty ClinicsStem Cell Banks/LaboratoriesOthersBy ApplicationCosmeticSoft-tissueOrthopedicOthersBy RegionNorth AmericaLatin AmericaEuropeAsia Pacific (APAC)South KoreaMiddle East and Africa (MEA)In its last part, the report offers insights on the key players competing in the global market for stromal vascular fraction.With detailed profiling of each of the key companies active on the competitive landscape, the report provides information about their current financial scenario, revenue share at a global level, development strategies, and future plans for expansion.Strategic collaborations, mergers, and acquisitions have also been considered as a key strategy among a majority of leading companies in the market.Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store